title: Protein kinase C epsilon regulation of translocator protein (18 kDa) Tspo gene expression is mediated through a MAPK pathway targeting STAT3 and c-Jun transcription factors.
abstract: Translocator protein TSPO is an 18 kDa protein implicated in numerous cell functions and is highly expressed in secretory and glandular tissues, especially in steroidogenic cells. TSPO expression is altered in pathological conditions such as certain cancers and neurological diseases. In search of the factors regulating Tspo expression, we recently showed that high levels of TSPO in steroidogenic cells may be due to high constitutive expression of protein kinase Cepsilon (PKCepsilon), while phorbol 12-myristate 13-acetate (PMA) activation of PKCepsilon drives inducible TSPO expression in nonsteroidogenic cells, likely through activator protein 1 (AP1). In this study, we aimed to identify the signal transduction pathway through which PKCepsilon regulates Tspo gene expression. The MEK1/2 specific inhibitor U0126, but not NFkappaB inhibitors, reduced basal Tspo promoter activity in TSPO-rich steroidogenic cells (MA-10 Leydig), as well as basal and PMA-induced Tspo promoter levels in TSPO-poor nonsteroidogenic cells (NIH-3T3 fibroblasts). AP1 and signal transducer and activation of transcription 3 (STAT3) have binding sites in the Tspo promoter and are downstream targets of PKCepsilon and MAPK (Raf-1-ERK1/2) pathways. PKCepsilon overexpression induced STAT3 phosphorylation in NIH-3T3 cells, while PKCepsilon knockdown reduced STAT3 and c-Jun phosphorylation in Leydig cells. MEK1/2, ERK2, c-Jun, and STAT3 knockdown reduced Tspo mRNA and protein levels in Leydig cells. Additionally, Raf-1 reduced Tspo mRNA levels in the same cells. MEK1/2, c-Jun, and STAT3 knockdown also reduced basal as well as PMA-induced Tspo mRNA levels in NIH-3T3 cells. Together, these results demonstrate that PKCepsilon regulates Tspo gene expression through a MAPK (Raf-1-MEK1/2-ERK1/2) signal transduction pathway, acting at least in part through c-Jun and STAT3 transcription factors.
authors.affiliation: Department of Biochemistry and Molecular and Cell Biology, Georgetown University Medical Center, Washington, DC 20057, USA.
authors.forename: Amani
authors.initials: A
authors.lastname: Batarseh
authors.forename: Jiehan
authors.initials: J
authors.lastname: Li
authors.forename: Vassilios
authors.initials: V
authors.lastname: Papadopoulos
mesh_terms: D000818:Animals; D019556:COS Cells; D045744:Cell Line, Tumor; D002522:Chlorocebus aethiops; D015971:Gene Expression Regulation, Enzymologic; D018390:Gene Targeting / Q000379:methods; D048369:MAP Kinase Kinase 1 / Q000502:physiology; D048370:MAP Kinase Kinase 2 / Q000502:physiology; D020935:MAP Kinase Signaling System / Q000235:genetics*; D051379:Mice; D041681:NIH 3T3 Cells; D011401:Promoter Regions, Genetic / Q000235:genetics; D051744:Protein Kinase C-epsilon / Q000502:physiology*; D016755:Proto-Oncogene Proteins c-jun / Q000378:metabolism* / Q000502:physiology; D019908:Proto-Oncogene Proteins c-raf / Q000502:physiology; D018079:Receptors, GABA / Q000096:biosynthesis* / Q000172:deficiency / Q000235:genetics*; D050796:STAT3 Transcription Factor / Q000172:deficiency / Q000235:genetics / Q000378:metabolism* / Q000502:physiology
chemical_list: C463819:Bzrp protein, mouse; D016755:Proto-Oncogene Proteins c-jun; D018079:Receptors, GABA; D050796:STAT3 Transcription Factor; C494087:Stat3 protein, mouse; D019908:Proto-Oncogene Proteins c-raf; D051744:Protein Kinase C-epsilon; D048369:MAP Kinase Kinase 1; D048370:MAP Kinase Kinase 2; C482127:Map2k1 protein, mouse; C482129:Map2k2 protein, mouse
references.citation: Antioxid Redox Signal. 2003 Oct;5(5):635-9
references.pmid: 14580320
references.citation: Clin Sci (Lond). 1990 Feb;78(2):155-8
references.pmid: 2155741
references.citation: Stem Cells. 1999;17(3):138-46
references.pmid: 10342556
references.citation: Endocrinology. 2002 Jul;143(7):2571-83
references.pmid: 12072389
references.citation: Biochemistry. 2008 Dec 2;47(48):12886-99
references.pmid: 18975922
references.citation: J Cell Biochem. 2006 Aug 15;98(6):1667-80
references.pmid: 16637058
references.citation: Clin Cancer Res. 2004 Mar 15;10(6):2058-64
references.pmid: 15041726
references.citation: Mol Cell Biol. 1999 Oct;19(10):7138-46
references.pmid: 10490649
references.citation: Endocrinology. 2004 Mar;145(3):1113-23
references.pmid: 14630713
references.citation: Biochem Pharmacol. 2003 Mar 1;65(5):717-29
references.pmid: 12628485
references.citation: Prog Growth Factor Res. 1989;1(2):69-77
references.pmid: 2518808
references.citation: Curr Pharm Des. 2007;13(23):2385-405
references.pmid: 17692008
references.citation: Nat Rev Cancer. 2007 Apr;7(4):281-94
references.pmid: 17384583
references.citation: Mol Carcinog. 2007 Aug;46(8):646-53
references.pmid: 17583567
references.citation: Cancer Res. 1999 Feb 15;59(4):831-42
references.pmid: 10029072
references.citation: Exp Neurol. 2009 Sep;219(1):53-7
references.pmid: 19409385
references.citation: J Biol Chem. 2001 Jul 13;276(28):26421-9
references.pmid: 11319221
references.citation: Trends Pharmacol Sci. 2006 Aug;27(8):402-9
references.pmid: 16822554
references.citation: Oncologist. 2002;7(1):17-33
references.pmid: 11854544
references.citation: Clin Cancer Res. 2002 Oct;8(10):3205-9
references.pmid: 12374690
references.citation: Proc Natl Acad Sci U S A. 1977 Sep;74(9):3805-9
references.pmid: 20632
references.citation: Cell Signal. 2009 May;21(5):745-52
references.pmid: 19168130
references.citation: Mol Endocrinol. 2003 Jan;17(1):11-26
references.pmid: 12511603
references.citation: Cell Res. 2008 Apr;18(4):436-42
references.pmid: 18347614
references.citation: J Biol Chem. 1988 May 15;263(14):6927-32
references.pmid: 2834397
references.citation: Cancer Res. 2007 Sep 15;67(18):8828-38
references.pmid: 17875724
references.citation: J Recept Signal Transduct Res. 2003;23(2-3):225-38
references.pmid: 14626449
references.citation: Mol Cell Biol. 2007 Sep;27(18):6300-8
references.pmid: 17636030
references.citation: J Biol Chem. 2007 Mar 2;282(9):6415-24
references.pmid: 17209045
references.citation: Pharmacol Rev. 1999 Dec;51(4):629-50
references.pmid: 10581326
references.citation: Biochemistry. 2007 Apr 24;46(16):4763-74
references.pmid: 17402746
references.citation: Neurochem Int. 2002 May;40(6):475-86
references.pmid: 11850104
references.citation: Steroids. 1997 Jan;62(1):21-8
references.pmid: 9029710